Correlation Between Ventyx Biosciences and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Ventyx Biosciences and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ventyx Biosciences and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ventyx Biosciences and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Ventyx Biosciences and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ventyx Biosciences with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ventyx Biosciences and Apellis Pharmaceuticals.
Diversification Opportunities for Ventyx Biosciences and Apellis Pharmaceuticals
0.7 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Ventyx and Apellis is 0.7. Overlapping area represents the amount of risk that can be diversified away by holding Ventyx Biosciences and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Ventyx Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ventyx Biosciences are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Ventyx Biosciences i.e., Ventyx Biosciences and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Ventyx Biosciences and Apellis Pharmaceuticals
Given the investment horizon of 90 days Ventyx Biosciences is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Ventyx Biosciences is 1.36 times more volatile than Apellis Pharmaceuticals. It trades about -0.07 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about -0.06 per unit of volatility. If you would invest 3,191 in Apellis Pharmaceuticals on November 1, 2024 and sell it today you would lose (244.00) from holding Apellis Pharmaceuticals or give up 7.65% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Ventyx Biosciences vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Ventyx Biosciences |
| Apellis Pharmaceuticals |
Ventyx Biosciences and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Ventyx Biosciences and Apellis Pharmaceuticals
The main advantage of trading using opposite Ventyx Biosciences and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ventyx Biosciences position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Ventyx Biosciences vs. Arcellx | Ventyx Biosciences vs. Immunocore Holdings | Ventyx Biosciences vs. Vaxcyte | Ventyx Biosciences vs. Nuvalent |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |